China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock
Equities
600062
CNE000000Q94
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.77 CNY | +2.01% | +2.69% | +17.04% |
Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
Apr. 26 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication | MT |
Sales 2024 * | 11.36B 1.58B | Sales 2025 * | 12.64B 1.75B | Capitalization | 22.23B 3.08B |
---|---|---|---|---|---|
Net income 2024 * | 1.52B 211M | Net income 2025 * | 1.71B 238M | EV / Sales 2024 * | 1.96 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.76 x |
P/E ratio 2024 * |
14.9
x | P/E ratio 2025 * |
13.2
x | Employees | - |
Yield 2024 * |
1.38% | Yield 2025 * |
1.56% | Free-Float | 38.65% |
1 day | +2.01% | ||
1 week | +2.69% | ||
1 month | +5.17% | ||
3 months | +27.31% | ||
6 months | +31.86% | ||
Current year | +17.04% |
Managers | Title | Age | Since |
---|---|---|---|
Wen Chao Lu
CHM | Chairman | - | 23-09-20 |
Li Hong Zheng
IRC | Investor Relations Contact | - | - |
Zhiyong Ge
PRN | Corporate Officer/Principal | 61 | 06-06-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mao Zhu Sun
BRD | Director/Board Member | 65 | 21-07-11 |
Ning Liu
BRD | Director/Board Member | 66 | 06-05-29 |
Wei Zheng
BRD | Director/Board Member | 64 | 18-06-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 21.77 | +2.01% | 16,512,340 |
24-04-29 | 21.34 | +0.66% | 12,655,700 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.04% | 3.07B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- 600062 Stock